London, United Kingdom, October 10, 2017 --(PR.com
)-- Due to overwhelming interest, SMi Group have added more content onto the agenda for their 10th annual European conference and exhibition on Pre-Filled Syringes taking place on 17th and 18th January in Central London. The updated programme is available at www.pre-filled-syringes.com/prcom.
Notable highlights will include:
An opening keynote address by the MHRA. This will be followed by insight into guidelines for auto injector requirements and the updated USP<1207>. Current policy within the EU and US framework will also be discussed.
Lessons learnt to overcome global challenges in combination products through a case study on cardiovascular risk reduction by Novartis Pharma.
Terumo Pharmaceutical Solutions discuss the importance for minimising risks of protein interaction with surfaces and materials of the container closure system, to eliminate immunogenicity and ensure drug safety and efficacy.
Worrell explores innovative mixed reality and voice-enabled technologies to improve medication, therapy adherence and long-term patient engagement.
Shire discusses who to facilitate meaningful differentiation of products by establishing a culture of innovation through existing platforms and guiding principles.
West Pharmaceuticals and Janssen discuss patient centricity and human factors on the path to safe injectables. Attendee’s will hear about common user problems, statistics and legislation for safety systems and learn more on why human-centred design matters.
Boehringer Ingelheim and Nemera offer informed guidance on primary packaging material selection, drug product stability, manufacturing, large volume injectables and device safety to meet specialised demands in parenteral drug products.
Mitsubishi Gas Chemical showcase new technologies in multilayer plastic syringes and component design to optimise PFS performance.
Amgen and UCB bridge the gap in drug delivery innovation through cutting edge insight into future technological developments surrounding vials, IV, handheld injectors and wearable devices.
Novo Nordisk and Intertek draw from case studies on leachable assessment in prefilled syringes to mitigate risk in chemical compatibility.
Lonza provides strategic direction on how to overcome hurdles in the development and application of highly concentrated formulations through insight into protein stability, device functionality, highly concentration formulations and SC volume limitations.
SMi’s 10th annual 2018 Pre-Filled Syringes Europe conference and exhibition will take place on 17th & 18th Jan at the Copthorne Tara Hotel, Kensington, London, UK.
Further information including a detailed agenda and full speaker line-up is available at http://www.pre-filled-syringes.com/prcom
For media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: firstname.lastname@example.org
For all other enquires contact the team on Tel: +44 (0)20 7827 6000 or email email@example.com
Sponsors of Pre-Filled Syringes Europe 2018 include: Früh Verpackungstechnik AG, Intertek (Schweiz) AG, Mitsubishi Gas Chemical, Nemera, Nipro PharmaPackaging, Owen Mumford, Panasonic Healthcare, Terumo Pharmaceutical Solutions, West Pharmaceutical Services, Worrell, Inc.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk